Clinical Pharmacy, Emergency Medicine, Uncategorized

Episode 111. Pulse Check! Kyle Stupca’s Study on Esmolol & Dose-Capped Epi

PACUPrep BCEMP 6 Week Fasttrack Program
PACUPrep – 6 Week Fastrack – Pharmacy & Acute Care University (pharmacy-acutecareuniversity.com)

This Pharm So Hard episode titled “Pulse Check! Kyle Stupca’s Study on Esmolol & Dose-Capped Epi” is a deep dive into the innovative research conducted by Kyle Stupca on emergency cardiac care. The episode hosted by Jimmy Pruitt aims to explore Stupca’s groundbreaking study which focuses on the use of Esmolol and dose-capped epinephrine in treating life-threatening cardiac arrhythmias like ventricular fibrillation and pulseless ventricular tachycardia. The discussion covers Stupca’s personal journey and motivations in emergency medicine research, delves into the specifics of his study’s methodology, findings, and the challenges faced during research. A significant part of the episode is dedicated to discussing the practical implications of these findings for emergency cardiac care and envisaging the future of this field with unlimited research resources. This episode is designed to enlighten healthcare professionals, particularly pharmacists and physicians, about the evolving role of pharmacology in emergency medical scenarios, emphasizing the critical impact of research in this domain.

Link to the Study

Kyle Stupca LinkedIn

EMPoweRx Conference

PACUPrep BCEMP Question Bank

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | RSS | http://pharmsohard.com/

ABOUT AUTHOR

Posted On

February 16, 2024

By

Jimmy Pruitt

New Episodes on 1st, 2nd, 4th Tuedays

Stay Connected to Get The Latest Podcast Alerts

Want to learn more?

Pharmacy and Acute Care University

An e-learning platform that empowers healthcare providers with knowledge and skills so they can provide evidence-based, safe care for these types of patients.

SITE

Subscribe to our Newsletter

Be the first to read our articles and updates

Episode 111. Pulse Check! Kyle Stupca’s Study on Esmolol & Dose-Capped Epi